PhD , Chief Commercial & Strategy Officer, Promethera and Managing Director, Promethera LLC (USA)
Dr. Hombeck leads Promethera’s overall commercial and pre-commercialization activities. He is also responsible for Promethera’s general strategy, including market access, pricing and re-imbursement and regulatory filing strategies for its lead product candidate families HepaStem, H2Stem and Heparec®. Torsten is an executive in the life science industry with over 15 years with U.S. and European experience in public and private biopharmaceutical companies. Torsten has been Co-CEO and CBO of Cytonet, Co-CEO and CFO of Agennix and CFO of GPC Biotech. Torsten received a MBA and PhD in Finance from the European Business School of Business and Law, Oestrich-Winkel, Germany.